Dear Friends,

As we have had to cancel our annual scientific meeting in Cardiff this year, we have offered to our sponsoring companies the opportunity to send pre-recorded symposia content which will be available to watch on this website.

Symposia are available free of charge to both members and non-members. However, due to pharmaceutical company regulations these are restricted to professionals working in the clinical setting, clinical research or basic science. Please note we will need to check eligibility before sending an access link/code.

As additional symposia are submitted then we will add them to this site. Each symposium will be available on line for five months.

The ILAE  British Chapter has received unrestricted educational funds to be able to make these symposia available, and we are very grateful to each Pharma company  for this funding.

Matthew Walker, President, ILAE British Branch

Ucb Symposium:

 We are delighted to invite you to view this UCB sponsored on demand webinar discussing generalised tonic-clonic seizures in epilepsy. The session is opened by a presentation from Dr Manuel Toledo, Vall d’Hebron Hospital, Barcelona, where he discusses the burden and unmet need in his talk; ‘How Soon is Soon Enough for Patients with Generalised Tonic-Clonic Seizures?’ 

His presentation is then followed by lively discussion and clinical case presentations from Professor Philippe Ryvlin, Lausanne University Hospital, Switzerland and Professor John Paul Leach, Queen Elizabeth University Hospital, Glasgow, UK. 

We hope you enjoy this 30 minute webinar. 

UCB Pharma Ltd have sponsored the hosting of this webinar on the ILAE website. 

Date or Prep January 2021 IE-P-BR-EPOS-2100002 w

The ILAE  British Chapter has received unrestricted educational funds to be able to make these symposia available, and we are very grateful to GW Pharma for this funding.

GW Pharma Symposium:

This symposium brings together international experts to discuss the management of patients with GW Cannabidiol in seizures associated with Dravet Syndrome and Lennox-Gastaut Syndrome, in conjunction with clobazam, from ages 2 years and above. This will include sharing clinical experience, considerations for starting and maintaining patients as well as management of adverse events.

The expected outcome of the presentation being that health care professionals would be educated and informed by a group of experts on the use of GW cannabidiol.

Prescribing Information can be found on https://www.emcpi.com/pi/37042

The ILAE  British Chapter has received unrestricted educational funds to be able to make these symposia available, and we are very grateful to GW Pharma for this funding.

The International League Against Epilepsy is the premier professional association of doctors and other health professionals who are working in the field of epilepsy.  The organisation comprises national chapters in over 100 countries in all continents of the world. The ILAE was founded in 1909 and the British branch was one of the founding members. It has held meetings since 1913 and is one of only 2 national ILAE branches that have been in continual existence since the origins of the League.

The ILAE mission globally is to ensure that health professionals, patients and their care providers, governments, and the public world-wide have the educational and research resources that are essential in understanding, diagnosing and treating persons with epilepsy. Its goals are: to advance and disseminate knowledge about epilepsy, to promote research, education and training, and to improve services and care for patients, especially by prevention, diagnosis and treatment.

The ILAE British branch has the following objectives:

1. To assist in the dissemination of knowledge and good practice in all aspects of epilepsy, and stimulate interest in the clinical, social and scientific aspects of the disorder.

2.  Co-ordinate the activities of those interested in the better care and treatment of those people with epilepsy.

3.  Actively participate in the business of the ILAE.

These objectives are fulfilled through a variety of activities of the chapter, including advocacy, holding educative and scientific meetings and workshops, and supporting members from bursaries and grants. Over the years the British chapter has had a major influence on the development of knowledge and services for epilepsy in the UK. It has contributed extensively to the international organisation, with two branch members serving as ILAE Presidents, three as ILAE treasurer, two as ILAE Vice-Presidents and three as Editors of the ILAE Journal Epilepsia. British members have been represented on the small ILAE executive committee in most of the years of its existence, and are currently serve on the ILAE Executive, its European Commission and on various of its topic-related Commissions

The branch is administered by a Branch Secretariat. Membership is open to any professional person working in the field of epilepsy in Britain, who expresses an interest in furthering the objectives of the Organisation. For further details, please contact members@ilaebritish.org.uk .

Website of ILAE British Branch is ilaebritish.org.uk and of ILAE internationally is www.ilea.org